Latest Insights, Interviews, News, and Resources.

£102m UK Innovation Science and Seed Fund prioritises Defence and Security Investment into UK-based startups

Machine Discovery Secures £4.5 Million to Deliver AI Tools For Semiconductor Design

Machine Discovery, a software company which uses machine learning technology to accelerate compute-intensive optimisation and simulation tasks, has secured £4.5-million of funding…

twig emerges from stealth with £3m in funding, to create a new bioengineering powerhouse in the UK

The new start-up will harness an AI-first approach to develop eco-friendly alternatives to everyday ingredients in consumer goods.

HALO X-ray Secures Investment to Accelerate its Disruptive X-ray Diffraction Technology for Security Screening and Contraband Detection

Investments in HALO X-ray Technologies will support regulatory approval of the first fieldable XRD system in checkpoint security…

UKI2S tops £100 million to provide UK economic boost

Investment in the UK Innovation & Science Seed Fund (UKI2S), a driving force in supporting early-stage innovation and high-impact businesses, now totals £102m

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

Bacterial resistance to antibiotics is growing as a critical worldwide challenge, often stated as the next potential pandemic.

UKI2S 2022 year in review

It’s been an exciting year for UKI2S, with £37 million additional capital into the fund, expansion of our role to include investments into Defence and Security and Fusion…

CEO Spotlight: Iain Miller, CEO of PreSymptom Health

You develop an instinct through your career. Like an experienced driver, you start to see problems before they happen, you come to know that the car at the junction ahead might come out…

What makes an exceptional start-up leader?

Start ups may be founded by an individual with a grand vision but almost as soon as they raise the first pound a founder is joined by a nascent and fast growing team.

The role of seed funding in net zero solutions

Funding early-stage technology companies is critical for turning innovation and science into real world solutions, including those which will help us adapt to and combat climate change.

Tokamak Energy announces ST80-HTS advanced prototype on path to demonstrate grid ready fusion power in the early 2030s

Tokamak Energy today announces plans for its advanced prototype, ST80-HTS, which will be the world’s first high field spherical tokamak using high temperature superconducting…

CEO Spotlight: Gary Owen, CEO of Lineat Composites

As the world transitions towards hydrogen storage, there is increasing demand for storage vessels which are made from carbon fibre.

Silveray announces £2.2M seed round for ultra-efficient X-ray detector technology

Surrey University spin-out company raises £1.5M in a seed round led by UKI2S to commercialise a novel nano-material that makes X-ray detectors more efficient and promises a more viable route to wide area detector panels.

NAMSA acquires UK-based Perfectus Biomed Group to enhance customised microbiological solutions

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group…

How public sector knowledge assets can contribute to economic growth

In April 2021, HM Treasury published a new report (‘Getting smarter: a strategy for knowledge & innovation assets in the public sector’) to support the effective management of public…

Smart Green Shipping announces £5m investment into FastRig wing sail technology

Three-year project backed by the Scottish Government and industry will develop and test fully automated, emission-reduction sail technology that can be retrofitted to merchant ships.

UK space companies’ partnership completed the development of an advanced deployable SAR antenna payload

Oxford Space Systems (OSS) and Surrey Satellite Technology Ltd (SSTL) have completed the build of an innovative deployable Synthetic Aperture Radar (SAR) antenna payload for the next…

CHAIN Biotech appoints new Chief Executive

CHAIN announces the appointment of Dr Matthew Duchars as Chief Executive from the 1st of August 2022.

CEO Spotlight: Jon Rees, CEO of MitoRx Therapeutics

MitoRx is a preclinical research stage biotechnology company developing first-in-class, orally available, mitochondrial protective therapeutics targeting rare…

Nemesis Bioscience awarded €2m EIC accelerator grant

Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC) Accelerator grant of €2 million to advance its work in the prevention of antibiotic-resistant infections.

Mirico accelerates climate change monitoring with investment led by Shell Ventures

Mirico announced today that it had raised £2m to accelerate roll out of its greenhouse gas emissions monitoring solutions.

Nemesis bioscience announces the appointment of Dr Yoshinori Yamano as non-executive director

Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director.

Science Ventures Series: Valuation of start-ups as a seed investor

We base our business model on the “power law” and estimate two out of ten early-stage investments will generate extraordinary financial return to cover the entire value of the fund.